These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 36813793)

  • 21. Antibiotic resistance of microbial strains isolated from Korean acne patients.
    Moon SH; Roh HS; Kim YH; Kim JE; Ko JY; Ro YS
    J Dermatol; 2012 Oct; 39(10):833-7. PubMed ID: 22779738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heterogeneity and antibiotic resistance in Propionibacterium acnes isolates and its therapeutic implications: blurring the lines between commensal and pathogenic phylotypes.
    Sadhasivam S; Sinha M; Saini S; Kaur SP; Gupta T; Sengupta S; Ghosh S; Sardana K
    Dermatol Ther; 2016 Nov; 29(6):451-454. PubMed ID: 27424878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospects of Phage Application in the Treatment of Acne Caused by
    Jończyk-Matysiak E; Weber-Dąbrowska B; Żaczek M; Międzybrodzki R; Letkiewicz S; Łusiak-Szelchowska M; Górski A
    Front Microbiol; 2017; 8():164. PubMed ID: 28228751
    [No Abstract]   [Full Text] [Related]  

  • 24. Transconjugation of erm(X) conferring high-level resistance of clindamycin for Cutibacterium acnes.
    Aoki S; Nakase K; Hayashi N; Noguchi N
    J Med Microbiol; 2019 Jan; 68(1):26-30. PubMed ID: 30431414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between the severity of acne vulgaris and antimicrobial resistance of bacteria isolated from acne lesions in a hospital in Japan.
    Nakase K; Nakaminami H; Takenaka Y; Hayashi N; Kawashima M; Noguchi N
    J Med Microbiol; 2014 May; 63(Pt 5):721-728. PubMed ID: 24523159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibiotic susceptibility of Propionibacterium acnes isolated from acne vulgaris in Korea.
    Song M; Seo SH; Ko HC; Oh CK; Kwon KS; Chang CL; Kim MB
    J Dermatol; 2011 Jul; 38(7):667-73. PubMed ID: 21352337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lactobacillus paraplantarum THG-G10 as a potential anti-acne agent with anti-bacterial and anti-inflammatory activities.
    Cha H; Kim SK; Kook M; Yi TH
    Anaerobe; 2020 Aug; 64():102243. PubMed ID: 32712375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PEG-8 Laurate Fermentation of
    Marito S; Keshari S; Huang CM
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32707723
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Rationally Designed Multifunctional Antibiotic for the Treatment of Drug-Resistant Acne.
    Ghosh S; Sinha M; Bhattacharyya A; Sadhasivam S; Megha J; Reddy S; Saini S; Singh H; Kumar D; Kaur SP; Mishra M; Usharani D; Ghosh S; Sengupta S
    J Invest Dermatol; 2018 Jun; 138(6):1400-1408. PubMed ID: 29409921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of oral antibiotics in treating acne vulgaris: a new approach.
    Farrah G; Tan E
    Dermatol Ther; 2016 Sep; 29(5):377-384. PubMed ID: 27306750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multicenter cross-sectional observational study of antibiotic resistance and the genotypes of Propionibacterium acnes isolated from Chinese patients with acne vulgaris.
    Fan Y; Hao F; Wang W; Lu Y; He L; Wang G; Chen W
    J Dermatol; 2016 Apr; 43(4):406-13. PubMed ID: 26508505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibiotic resistance of Propionibacterium acnes in acne vulgaris.
    Swanson JK
    Dermatol Nurs; 2003 Aug; 15(4):359-62. PubMed ID: 14515616
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between quinolone use and resistance of Staphylococcus epidermidis in patients with acne vulgaris.
    Nakase K; Yoshida A; Saita H; Hayashi N; Nishijima S; Nakaminami H; Noguchi N
    J Dermatol; 2019 Sep; 46(9):782-786. PubMed ID: 31254314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent advances in understanding
    Platsidaki E; Dessinioti C
    F1000Res; 2018; 7():. PubMed ID: 30613388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Shiunko and Chuoko, topical Kampo medicines, inhibit the expression of gehA encoding the extracellular lipase in Cutibacterium acnes.
    Nakase K; Tashiro A; Yamada T; Ikoshi H; Noguchi N
    J Dermatol; 2019 Apr; 46(4):308-313. PubMed ID: 30803018
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro antibiotic susceptibility patterns of Propionibacterium acnes isolated from acne patients: an Egyptian university hospital-based study.
    Abdel Fattah NS; Darwish YW
    J Eur Acad Dermatol Venereol; 2013 Dec; 27(12):1546-51. PubMed ID: 23279041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acne vaccines targeting Propionibacterium acnes.
    Kao M; Huang CM
    G Ital Dermatol Venereol; 2009 Dec; 144(6):639-43. PubMed ID: 19907403
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent advances in understanding inflammatory acne: Deciphering the relationship between Cutibacterium acnes and Th17 inflammatory pathway.
    Mias C; Mengeaud V; Bessou-Touya S; Duplan H
    J Eur Acad Dermatol Venereol; 2023 Mar; 37 Suppl 2():3-11. PubMed ID: 36729400
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intradermal injection of Cutibacterium acnes and staphylococcus: A pustular acne-like murine model.
    Zhou N; Sun Y; Ren X; Wang Y; Gao X; Li L; Ma Y; Hao Y; Wang Y
    J Cosmet Dermatol; 2024 Jul; 23(7):2478-2489. PubMed ID: 38581133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Propionibacterium acnes bacteriophages display limited genetic diversity and broad killing activity against bacterial skin isolates.
    Marinelli LJ; Fitz-Gibbon S; Hayes C; Bowman C; Inkeles M; Loncaric A; Russell DA; Jacobs-Sera D; Cokus S; Pellegrini M; Kim J; Miller JF; Hatfull GF; Modlin RL
    mBio; 2012; 3(5):. PubMed ID: 23015740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.